---
title: "GAROFALO ELIZABETH A. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ce564ed4-3992-5331-95c5-8dc5c577e796
json: https://whiteintel.dev/api/public/dossier/ce564ed4-3992-5331-95c5-8dc5c577e796
identifier: sec:0001826361
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GAROFALO ELIZABETH A.

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001826361`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ce564ed4-3992-5331-95c5-8dc5c577e796  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ce564ed4-3992-5331-95c5-8dc5c577e796  

## Ownership & control

### Holdings / subsidiaries

- **ACADIA PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/e0daead6-1fdc-534a-ae81-4152b4e37d9f
- **Alector, Inc.** (director) — https://whiteintel.dev/entity/39aa5ecb-dfad-52e0-99bd-faeeed41c794
- **Xenon Pharmaceuticals Inc.** (director) — https://whiteintel.dev/entity/3e20a2da-c4ad-5d3e-8c87-9dd6b2938172
- **ACADIA PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/e0daead6-1fdc-534a-ae81-4152b4e37d9f
- **EXICURE, INC.** (director) — https://whiteintel.dev/entity/3149d66e-9724-5e12-8ca4-2d686629a6b9

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GAROFALO ELIZABETH A.**. Human view: https://whiteintel.dev/entity/ce564ed4-3992-5331-95c5-8dc5c577e796 · Structured JSON: https://whiteintel.dev/api/public/dossier/ce564ed4-3992-5331-95c5-8dc5c577e796._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._